Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 2 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 1 day agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 20 hours agoAdalja says. Will the fall COVID-19 vaccine protect against KP.3? The U.S. Food and Drug ...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 21 hours agoDive Brief: The Food and Drug Administration on Monday approved a new vaccine from Merck & Co. that...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
US FDA puts partial clinical hold on BioNTech’s early-stage study of cancer drug
WHTC 1450 Holland· 2 days ago(Reuters) - Germany's BioNTech SE said in a regulatory filing on Monday the U.S. Food and Drug ...
US FDA approves Merck’s pneumococcal vaccine for adults
WSAU Wausau· 1 day ago(Reuters) - Merck said on Monday the U.S. Food and Drug Administration has approved its...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 23 hours agoIn a lawsuit filed on Monday, the U.S. state alleges Pfizer made false statements about the safety...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life· 4 days agoUltimately, however, there aren’t many medical options for those suffering from Alzheimer’s — and...